Sepsis-induced endothelial dysfunction drives acute-on-chronic liver failure through Angiopoietin-2-HGF-C/EBPβ pathway
- 22 March 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 78 (3) , 803-819
Abstract
Background and Aims: Acute-on-chronic liver failure (ACLF) is an acute liver and multisystem failure in patients with previously stable cirrhosis. A common cause of ACLF is sepsis secondary to bacterial infection. Sepsis-associated ACLF involves a loss of differentiated liver function in the absence of direct liver injury, and its mechanism is unknown. We aimed to study the mechanism of sepsis-associated ACLF using a novel mouse model. Approach and Results: Sepsis-associated ACLF was induced by cecal ligation and puncture procedure (CLP) in mice treated with thioacetamide (TAA). The combination of TAA and CLP resulted in a significant decrease in liver synthetic function and high mortality. These changes were associated with reduced metabolic gene expression and increased CCAAT enhancer binding protein beta (C/EBPβ) transcriptional activity. We found that C/EBPβ binding to its target gene promoters was increased. In humans, C/EBPβ chromatin binding was similarly increased in the ACLF group compared with control cirrhosis. Hepatocyte-specific Cebpb knockout mice had reduced mortality and increased gene expression of hepatocyte differentiation markers in TAA/CLP mice, suggesting that C/EBPβ promotes liver failure in these mice. C/EBPβ activation was associated with endothelial dysfunction, characterized by reduced Angiopoietin-1/Angiopoietin-2 ratio and increased endothelial production of HGF. Angiopoietin-1 supplementation or Hgf knockdown reduced hepatocyte C/EBPβ accumulation, restored liver function, and reduced mortality, suggesting that endothelial dysfunction induced by sepsis drives ACLF through HGF-C/EBPβ pathway. Conclusions: The transcription factor C/EBPβ is activated in both mouse and human ACLF and is a potential therapeutic target to prevent liver failure in patients with sepsis and cirrhosis.Keywords
This publication has 31 references indexed in Scilit:
- Identification of target genes of transcription factor CEBPB in acute promyelocytic leukemia cells induced by all-trans retinoic acidAsian Pacific Journal of Tropical Medicine, 2013
- Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteriesGenome Research, 2013
- Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2013
- CCAAT/Enhancer-Binding Proteins (C/EBP)-α and -β Are Essential for Ovulation, Luteinization, and the Expression of Key Target GenesMolecular Endocrinology, 2011
- The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation controlTrends in Cell Biology, 2007
- Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cellsBlood, 2006
- C/EBPβ contributes to hepatocyte growth factor-induced replication of rodent hepatocytesJournal of Hepatology, 2005
- Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liverHepatology, 2001
- CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy.Journal of Clinical Investigation, 1998
- C/EBP-β/LAP Controls Down-regulation of Albumin Gene Transcription during Liver RegenerationJournal of Biological Chemistry, 1996